Thomas J. Gergel, MD

Guthrie Provider

Specialties:

Provider Reviews: 
19
  • Clinical Details
  • Education
  • Clinical Trials
Hospital Privileges: 
  • Guthrie Robert Packer Hospital
Clinical Interests: 
  • Brain tumors
  • Breast Cancer
  • Lung Cancer
  • Stereotactic radiation therapy
Residency: 
  • Roswell Park Cancer Institute, Buffalo, N.Y. (Radiation Oncology)
Certification: 
  • American Board of Radiology
Education: 
  • University of Buffalo School of Medicine, Buffalo, N.Y.
Internship: 
  • Hinsdale Hospital, Hinsdale, Ill. (Family Medicine)
Department: Oncology
Diagnosis: Breast
Principal Investigator: Gergel MD, Thomas
Sponsor: ALLIANCE
Details (Identifier #): NCT01901094
Title: A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Department: Oncology
Diagnosis: Breast
Principal Investigator: Gergel MD, Thomas
Sub-Investigator(s):
Sponsor: ALLIANCE
Details (Identifier #): NCT03414970
Title: A221505, Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Department: Oncology
Diagnosis: Genito-urinary - Prostate
Principal Investigator: Gergel MD, Thomas
Sub-Investigator(s):
Sponsor: NRG
Details (Identifier #): NCT03371719
Title: NRG-GU006: A PHASE II, DOUBLE-BLINDED, PLACEBO-CONTROLLED RANDOMIZED TRIAL OF SALVAGE RADIOTHERAPY WITH OR WITHOUT ENHANCED ANTI-ANDROGEN THERAPY WITH APALUTAMIDE IN RECURRENT PROSTATE CANCER
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Gergel MD, Thomas
Sponsor: NRG
Details (Identifier #): NCT0313771
Title: NRG-LU002: Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Department: Oncology
Diagnosis: Breast- Adjuvant
Principal Investigator: Gergel MD, Thomas
Sponsor: NRG
Details (Identifier #): NCT01872975
Title: NSABP-B-51: A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Guthrie Patient: September 2018
At this time I have a total - confidence in him & his knowledge of my condition. I have not had a 2nd conference with him & will be concluding my radiation so do not know what I will expect from him in the future, etc. Highly satisfied so far.
Guthrie Patient: July 2018
Good.
Guthrie Patient: March 2018
Very good, very thorough.